Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Gemcitabine/docetaxel for NMIBC appears safe and efficacious.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): MIAN, BADAR M.
- Source:
Urology Times. May2023, Vol. 51 Issue 5, p17-17. 1p.
- Additional Information
- Subject Terms:
- Abstract:
The article discusses research which compared the safety and efficacy of intravesical gemcitabine/docetaxel to intravesical Bacillus Calmette-Guerin (BCG) as treatment for non-muscle invasive bladder cancer (NMIBC) after transurethral resection of the bladder tumor. It references a study by I. M. McElree et al published in a 2023 issue of "JAMA Network Open." Cited are the characteristics of study patients, the mechanism of action of both treatments, and the tolerability of the treatments.
No Comments.